Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies on the mechanism of action of dantrolene sodium. A skeletal muscle relaxant.

× No keyword cloud information.

16 in total

1. CALCIUM AND THE CONTRACTION OF MAIA MUSCLE FIBRES.

Authors: P C CALDWELL
Journal: Proc R Soc Lond B Biol Sci Date: 1964-10-27

2. PHASE PLANE TRAJECTORIES OF THE MUSCLE SPIKE POTENTIAL.

Authors: H JENERICK
Journal: Biophys J Date: 1963-09 Impact factor: 4.033

Review 3. POTENTIATION OF MUSCULAR CONTRACTION.

Authors: A SANDOW
Journal: Arch Phys Med Rehabil Date: 1964-02 Impact factor: 3.966

4. Activation of the contractile mechanism in striated muscle.

Authors: J AXELSSON; S THESLEFF
Journal: Acta Physiol Scand Date: 1958-10-28

5. Effects of changes in extracellular calcium concentration on the potassium-induced contracture of frog's skeletal muscle.

Authors: G B FRANK
Journal: J Physiol Date: 1960-06 Impact factor: 5.182

6. 1-[(5-arylfurfurylidene)amino]hydantoins. A new class of muscle relaxants.

Authors: H R Snyder; C S Davis; R K Bickerton; R P Halliday
Journal: J Med Chem Date: 1967-09 Impact factor: 7.446

7. Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium.

Authors: K O Ellis; S H Bryant
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1972 Impact factor: 3.000

8. The use of dantrolene sodium in disorders of the central nervous system.

Authors: S B Chyatte; J H Birdsong
Journal: South Med J Date: 1971-07 Impact factor: 0.954

9. Action potentials without contraction in frog skeletal muscle fibers with disrupted transverse tubules.

Authors: P W Gage; R S Eisenberg
Journal: Science Date: 1967-12-29 Impact factor: 47.728

10. INHIBITION OF CAFFEINE RIGOR AND RADIOCALCIUM MOVEMENTS BY LOCAL ANESTHETICS IN FROG SARTORIUS MUSCLE.

Authors: M B FEINSTEIN
Journal: J Gen Physiol Date: 1963-09 Impact factor: 4.086

37 in total

1. Dantrolene sodium in the management of spasticity.

Authors: A Glass
Journal: West J Med Date: 1974-08

2. Modification by dantrolene, procaine and suxamethonium of caffeine-induced changes in aequorin luminescence transients and twitch tensions of directly-stimulated diaphragm muscle of mouse.

Authors: I Kimura; M Kimura; M Kimura
Journal: Br J Pharmacol Date: 1985-10 Impact factor: 8.739

3. Pharmacokinetic evaluation of oral dantrolene in the dog.

Authors: J L Haraschak; V C Langston; R Wang; C Riggs; C Fellman; M K Ross; C Bulla; K Lunsford; A Mackin; T Archer
Journal: J Vet Pharmacol Ther Date: 2013-11-13 Impact factor: 1.786

4. Effects of dantrolene and its derivatives on Ca(2+) release from the sarcoplasmic reticulum of mouse skeletal muscle fibres.

Authors: T Ikemoto; T Hosoya; H Aoyama; Y Kihara; M Suzuki; M Endo
Journal: Br J Pharmacol Date: 2001-10 Impact factor: 8.739

Review 5. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.

Authors: R M Pinder; R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1977-01 Impact factor: 9.546

6. The action of caffeine in promoting ultrastructural damage in frog skeletal muscle fibres. Evidence for the involvement of the calcium-induced release of calcium from the sarcoplasmic reticulum.

Authors: C J Duncan; J L Smith
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1978-11 Impact factor: 3.000

Review 10. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors: A Ward; M O Chaffman; E M Sorkin
Journal: Drugs Date: 1986-08 Impact factor: 9.546

Studies on the mechanism of action of dantrolene sodium. A skeletal muscle relaxant.